Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
Mishra
M
M
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D010419:Pentamidine / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D010419:Pentamidine; D000666:Amphotericin B